Literature DB >> 9538230

A streptavidin-based neoglycoprotein carrying more than 140 GT1b oligosaccharides: quantitative estimation of the binding specificity of murine sialoadhesin expressed on CHO cells.

Y Hashimoto1, M Suzuki, P R Crocker, A Suzuki.   

Abstract

We prepared a streptavidin-based neoglycoprotein which carries more than 140 GT1b oligosaccharides. GT1b oligosaccharides were covalently coupled to streptavidin by reductive amination, yielding a monomer form of streptavidin carrying 13 oligosaccharides. The monomer form of glycosylated streptavidin was polymerized with biotinylated-bovine serum albumin, which yielded a polymer carrying more than 140 oligosaccharides. Both the monomer and the polymer bound to Chinese hamster ovary cells expressing murine sialoadhesin. The relative binding potencies determined with the polymer, monomer, and free GT1b oligosaccharides were 3,500, 83, and 1, respectively, indicating that an increase in the number of oligosaccharide ligands is critical for high avidity. The high avidity of the polymer enabled us to develop a sensitive and quantitative binding assay, and the assay was applied to characterization of the binding specificity of sialoadhesin. The polymer binding was inhibited by various gangliosides, the order of the inhibitory potencies being GM3 (IC50 = 40 microM) > GD1a (100 microM) > sialylparagloboside (120 microM) > GT1b (310 microM) > GM2 (640 microM) > GM4 (2,100 microM) > GD1b>LacCer = GM1 = paragloboside (no inhibition). These results indicate that the binding specificity is comparable to that reported, i.e. the determinant structure is NeuAcalpha2-3Galbeta1-linked to either 3GalNAc, 3(4)GlcNAc, or 4Glc, and that the oligosaccharide structure on the polymer is properly presented to sialoadhesin on the cell surface. To determine the precise requirement of the NeuAc structure for binding, NeuAc of GM3 was converted into various derivatives, the inhibitory potencies of which were examined; i.e. GM3 containing NeuAc, IC50 = 40 microM; C7- or C8-aldehyde, 500 microM; C7- or C8-alcohol, 700 microM; C1-alcohol, 2,000 microM; C1-amide, 2,200 microM; and NeuGc,>3,000 microM. These results confirmed the requirement of the hydroxyl group at C9 and/or C8, the carboxyl group at C1, and the methyl group of the N-acetyl residue of NeuAc in a quantitative manner. Thus, this streptavidin-based neoglycoprotein is a useful multivalent glycoprobe, which exhibits high affinity and specificity to murine sialoadhesin on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538230     DOI: 10.1093/oxfordjournals.jbchem.a021960

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  6 in total

Review 1.  Siglecs as sensors of self in innate and adaptive immune responses.

Authors:  James C Paulson; Matthew S Macauley; Norihito Kawasaki
Journal:  Ann N Y Acad Sci       Date:  2012-01-30       Impact factor: 5.691

Review 2.  Functional roles of glycosphingolipids in signal transduction via lipid rafts.

Authors:  K Kasahara; Y Sanai
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

Review 3.  Sialoadhesin in recognition of self and non-self.

Authors:  Mariliis Klaas; Paul R Crocker
Journal:  Semin Immunopathol       Date:  2012-03-27       Impact factor: 9.623

4.  Porcine arterivirus infection of alveolar macrophages is mediated by sialic acid on the virus.

Authors:  Peter L Delputte; Hans J Nauwynck
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

5.  Sialoadhesin ligand expression identifies a subset of CD4+Foxp3- T cells with a distinct activation and glycosylation profile.

Authors:  Dana Kidder; Hannah E Richards; Hermann J Ziltener; Oliver A Garden; Paul R Crocker
Journal:  J Immunol       Date:  2013-02-13       Impact factor: 5.422

Review 6.  Sialoadhesin - a macrophage-restricted marker of immunoregulation and inflammation.

Authors:  Alexander S G O'Neill; Timo K van den Berg; Gregory E D Mullen
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.